Pulse Wave Diagnosis Helps Estimate Cardiovascular Risk
By HospiMedica International staff writers Posted on 08 Apr 2014 |

Image: Dr. Empar Lurbe Ferrer conducting a fundus examination (Photo courtesy of Hospital General de Valencia).
New software helps clinicians assess future cardiovascular risk by examining the structure of the eye in children.
Researchers at Hospital General de Valencia (Spain), Universitat Politècnica de València (Spain), and the Ophthalmology Unit of the Foundation for the Health and Biomedical Research of the Comunitat Valenciana (FISABIO-Oftalmología Médica, Valencia, Spain) have developed specialized software to make an in-depth study of the retinal microvascular architecture in children born with low birth-weight.
Pediatric patients undergo various noninvasive tests and all of them are interpreted together, giving as a result an approximation of what is happening in the children’s vessels. Among the tests are pulse wave morphology and speed of the blood as it travels through the vessels, and how it returns. Another test is a fundus scan with a nonmydriatic retinal camera to define the caliber and the branching angle of the retinal vessels to understand blood circulation. The measurements can indicate if a child who has a different branching angle could have an increase in blood pressure over the years.
Using the software, the researchers and pediatricians are analyzing the relationship between the various measurements and adult diseases such as hypertension or cardiovascular problems. By learning more about the retinal attributes of these pathologies as they appear in the newborn, the researchers can possibly determine characteristics that could imply a higher cardiovascular risk when the child reaches adulthood.
“Children with intrauterine growth retardation are those who are at a greater risk of developing cardiovascular diseases, such as hypertension or type 2 diabetes,” said Empar Lurbe Ferrer, MD, head of the pediatrics unit at Hospital General de Valencia. “Because of this, we are using the measurements to see if the branching angles of the vessels of children who have intrauterine growth retardation are different than those who do not.”
“This joint work between engineers and pediatricians aims to provide better care for pediatric patients,” said telecommunication engineer Sandra Morales, a researcher at the LabHuman technology center of the Universitat Politècnica de València. “Our system permits us to establish objective connections between different vessels and help clinical staff to detect these pathologies at the earliest stage. As a result they will help give more personalized treatments.”
Related Links:
Hospital General de Valencia
Universitat Politècnica de València
Foundation for the Health and Biomedical Research of the Comunitat Valenciana
Researchers at Hospital General de Valencia (Spain), Universitat Politècnica de València (Spain), and the Ophthalmology Unit of the Foundation for the Health and Biomedical Research of the Comunitat Valenciana (FISABIO-Oftalmología Médica, Valencia, Spain) have developed specialized software to make an in-depth study of the retinal microvascular architecture in children born with low birth-weight.
Pediatric patients undergo various noninvasive tests and all of them are interpreted together, giving as a result an approximation of what is happening in the children’s vessels. Among the tests are pulse wave morphology and speed of the blood as it travels through the vessels, and how it returns. Another test is a fundus scan with a nonmydriatic retinal camera to define the caliber and the branching angle of the retinal vessels to understand blood circulation. The measurements can indicate if a child who has a different branching angle could have an increase in blood pressure over the years.
Using the software, the researchers and pediatricians are analyzing the relationship between the various measurements and adult diseases such as hypertension or cardiovascular problems. By learning more about the retinal attributes of these pathologies as they appear in the newborn, the researchers can possibly determine characteristics that could imply a higher cardiovascular risk when the child reaches adulthood.
“Children with intrauterine growth retardation are those who are at a greater risk of developing cardiovascular diseases, such as hypertension or type 2 diabetes,” said Empar Lurbe Ferrer, MD, head of the pediatrics unit at Hospital General de Valencia. “Because of this, we are using the measurements to see if the branching angles of the vessels of children who have intrauterine growth retardation are different than those who do not.”
“This joint work between engineers and pediatricians aims to provide better care for pediatric patients,” said telecommunication engineer Sandra Morales, a researcher at the LabHuman technology center of the Universitat Politècnica de València. “Our system permits us to establish objective connections between different vessels and help clinical staff to detect these pathologies at the earliest stage. As a result they will help give more personalized treatments.”
Related Links:
Hospital General de Valencia
Universitat Politècnica de València
Foundation for the Health and Biomedical Research of the Comunitat Valenciana
Latest Critical Care News
- Monitoring Airborne Fungal Spores Could Help Predict COVID-19 & Flu Surges
- New System Measures Blood Sodium Without Needles
- Sleep Data from Wearable Device May Help Predict Preterm Birth
- AI Tool Interprets Echocardiograms in Minutes
- Electrochemical Catheter Hub Prevents Bloodstream Infections
- Noninvasive Double Microbubble Delivery Approach Marks Breakthrough in Brain Cancer Treatment
- Self-Healing Skin-Like Material to Find Applications in Health Monitoring, Surgery and Implants
- Highly-Sensitive Electronic Skin Allows Robots to Feel Heat, Pain and Pressure
- AI-Powered Wearable Sensor Predicts Labor Onset in Pregnant Women
- Implantable Device to Redefine Continuous Glucose Monitoring
- Smart Microgel Could Repair and Replace Damaged Organs
- Smart Breath Tracker Wristband to Revolutionize Respiratory Care
- Stronger Blood Clot Prevention Measures Needed After Leg Artery Procedures in High-Risk Patients
- AI Tool Catches Missed Illnesses Associated with Inflammatory Bowel Disease
- First Ever Device Diagnoses Life-Threatening Complication Post-Cardiac Surgery
- Contactless Vital Sign Monitoring Device Measures Respiratory Rate Through Smartphones
Channels
Surgical Techniques
view channel
First-Ever Technology Makes Blood Translucent During Surgery
No matter the discipline or scale, bleeding is a regular part of any surgery and can create several challenges. In operating room imaging, seeing through blood in real-time during a surgery has been a... Read more
Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
Smith+Nephew (Hull, UK;) has launched its new TRIGEN MAX Tibia Nailing System for stable and unstable fractures of the tibia, including the shaft. It is the only system to now offer trauma surgeons the... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more